Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bohé, J.
Right arrow Articles by Fouque, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohé, J.
Right arrow Articles by Fouque, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 590-594
© 2001 European Renal Association-European Dialysis and Transplant Association

Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3

Julien Bohé1,, Marie-Odile Joly2, Walid Arkouche3, Maurice Laville3 and Denis Fouque3

1 Medical Intensive Care Unit, Lyon-Sud Hospital, Pierre-Bénite, 2 Department of Biochemistry, Debrousse Hospital, Lyon 3 Department of Nephrology and Hypertension, E Herriot Hospital, Lyon, France

Background. Insulin-like growth factor-I (IGF-I) bioactivity has been reported to be decreased in maintenance haemodialysis patients and this may affect their nutritional status. Clearances of IGF-I and its binding proteins (IGFBPs) during haemodialysis sessions using a high permeability biocompatible membrane are unknown.

Methods. Five well nourished, non-diabetic adult patients were studied during one 4-h morning haemodialysis treatment using the high permeability biocompatible AN-69 dialyser. Blood was collected at the arterial and venous ports of the dialyser at 0, 1, 2 and 4 h of dialysis for haematocrit, plasma IGF-I, IGFBP-3 and insulin measurements. IGF-I, IGFBP-3 and insulin concentrations were adjusted for haemoconcentration before comparisons were made.

Results. At the beginning of the dialysis session, plasma IGF-I, IGFBP-3 and insulin levels were within the normal range (297±47 ng/ml (mean±SEM), 4.3±0.6 µg/ml and 11.8±3.4 µIU/ml, respectively). During the session, insulin tended to be cleared through the dialyser, whereas plasma IGF-I and IGFBP-3 values did not vary significantly.

Conclusion. Dialysis with the high permeability AN69 membrane did not alter the main blood compounds of the IGF system in well nourished chronic haemodialysis patients, and it is unlikely that the malnutrition frequently observed in such patients would result from alterations of the IGF system during haemodialysis.

Keywords: haemodialysis; high permeability dialyser; insulin-like growth factor binding protein-3; insulin-like growth factor-I; nutrition

Correspondence and offprint requests to: Julien Bohé, Service de réanimation médicale, Centre Hospitalier Lyon-Sud, F-69495 Pierre Bénite, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Ferreira, A. Ghazali, J. Galvao, J.-C. Souberbielle, P. M. Jehle, S. Mohan, B. Descamps-Latscha, R. Oprisiu, A. Fournier, and T. B. Drueke
Effect of type of dialysis membrane on bone in haemodialysis patients
Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1230 - 1238.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.